Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) Net Margin (2023 - 2025)

Zenas BioPharma has reported Net Margin over the past 3 years, most recently at 335.73% for Q1 2025.

  • Quarterly results put Net Margin at 335.73% for Q1 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 107.72% (up 332606.0% YoY), and the annual figure for FY2025 was 107.72%, up 333466.0%.
  • Net Margin for Q1 2025 was 335.73% at Zenas BioPharma, up from 1130.68% in the prior quarter.
  • Over the last five years, Net Margin for ZBIO hit a ceiling of 71.25% in Q3 2023 and a floor of 1130.68% in Q4 2024.
  • Median Net Margin over the past 3 years was 335.73% (2025), compared with a mean of 465.05%.